BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 33444724)

  • 1. Anti-perimenopausal osteoporosis effects of Erzhi formula via regulation of bone resorption through osteoclast differentiation: A network pharmacology-integrated experimental study.
    Qin XY; Niu ZC; Han XL; Yang Y; Wei Q; Gao XX; An R; Han LF; Yang WZ; Chai LJ; Liu EW; Gao XM; Mao HP
    J Ethnopharmacol; 2021 Apr; 270():113815. PubMed ID: 33444724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of Ligustri Lucidi Fructus with Ecliptae Herba and their phytoestrogen or phytoandrogen like active pharmaceutical ingredients alleviate oestrogen/testosterone-induced benign prostatic hyperplasia through regulating steroid 5-α-reductase.
    Tao R; Liu E; Zhao X; Han L; Yu B; Mao H; Yang W; Gao X
    Phytomedicine; 2022 Jul; 102():154169. PubMed ID: 35636178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of bone and fat balance by Fructus Ligustri Lucidi in ovariectomized mice.
    Qin X; Wei Q; An R; Yang Y; Cai M; Han X; Mao H; Gao X
    Pharm Biol; 2023 Dec; 61(1):391-403. PubMed ID: 36740874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kirenol inhibits RANKL-induced osteoclastogenesis and prevents ovariectomized-induced osteoporosis via suppressing the Ca
    Zou B; Zheng J; Deng W; Tan Y; Jie L; Qu Y; Yang Q; Ke M; Ding Z; Chen Y; Yu Q; Li X
    Phytomedicine; 2021 Jan; 80():153377. PubMed ID: 33126167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Jiangu formula: A novel osteoclast-osteoblast coupling agent for effective osteoporosis treatment.
    Xu H; Lu X; Li M; Huang X; Yao N; Gan H; Huang X; Zhao Z; Hu Z; Zhao X; Lai Y; Li M; Chen S; Chen Y; Huang D
    Phytomedicine; 2024 Jun; 128():155501. PubMed ID: 38471318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cichoric acid targets RANKL to inhibit osteoclastogenesis and prevent ovariectomy-induced bone loss.
    Xian Y; Gao Y; Su Y; Su Y; Lian H; Feng X; Liu Z; Zhao J; Xu J; Liu Q; Song F
    Phytother Res; 2024 Apr; 38(4):1971-1989. PubMed ID: 38358727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of luteolin on osteoclast differentiation, function in vitro and ovariectomy-induced bone loss.
    Kim TH; Jung JW; Ha BG; Hong JM; Park EK; Kim HJ; Kim SY
    J Nutr Biochem; 2011 Jan; 22(1):8-15. PubMed ID: 20233653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glaucocalyxin A suppresses osteoclastogenesis induced by RANKL and osteoporosis induced by ovariectomy by inhibiting the NF-κB and Akt pathways.
    Zhu M; Shan J; Xu H; Xia G; Xu Q; Quan K; Liu X; Dai M
    J Ethnopharmacol; 2021 Aug; 276():114176. PubMed ID: 33933570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of JSOG-6 on protection against bone loss in ovariectomized mice through regulation of osteoblast differentiation and osteoclast formation.
    Chung HJ; Cho L; Shin JS; Lee J; Ha IH; Park HJ; Lee SK
    BMC Complement Altern Med; 2014 Jun; 14():184. PubMed ID: 24903150
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Kim JH; Shin H; Kim M; Kim S; Song K; Jung HS; Sohn Y
    Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34184079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Zuoguiwan on osteoporosis in ovariectomized rats through RANKL/OPG pathway mediated by β2AR.
    Liu F; Tan F; Tong W; Fan Q; Ye S; Lu S; Teng Z; Han M; Zhang M; Chai Y
    Biomed Pharmacother; 2018 Jul; 103():1052-1060. PubMed ID: 29710663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonate-enoxacin inhibit osteoclast formation and function by abrogating RANKL-induced JNK signalling pathways during osteoporosis treatment.
    Xu Q; Zhan P; Li X; Mo F; Xu H; Liu Y; Lai Q; Zhang B; Dai M; Liu X
    J Cell Mol Med; 2021 Nov; 25(21):10126-10139. PubMed ID: 34651433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-c-fms Antibody Prevents Osteoclast Formation and Bone Resorption in Co-Culture of Osteoblasts and Osteoclast Precursors In Vitro and in Ovariectomized Mice.
    Nara Y; Kitaura H; Ogawa S; Shen WR; Qi J; Ohori F; Noguchi T; Marahleh A; Pramusita A; Kinjo R; Mizoguchi I
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32854340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loureirin B suppresses RANKL-induced osteoclastogenesis and ovariectomized osteoporosis via attenuating NFATc1 and ROS activities.
    Liu Y; Wang C; Wang G; Sun Y; Deng Z; Chen L; Chen K; Tickner J; Kenny J; Song D; Zhang Q; Wang H; Chen Z; Zhou C; He W; Xu J
    Theranostics; 2019; 9(16):4648-4662. PubMed ID: 31367247
    [No Abstract]   [Full Text] [Related]  

  • 15. Pristimerin Inhibits Osteoclast Differentiation and Bone Resorption in vitro and Prevents Ovariectomy-Induced Bone Loss in vivo.
    Sun P; Yang Q; Wang Y; Peng J; Zhao K; Jia Y; Zhang T; Lu X; Han W; Qian Y
    Drug Des Devel Ther; 2020; 14():4189-4203. PubMed ID: 33116407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QingYan formula extracts protect against postmenopausal osteoporosis in ovariectomized rat model via active ER-dependent MEK/ERK and PI3K/Akt signal pathways.
    Zhao Y; Xu Y; Zheng H; Lin N
    J Ethnopharmacol; 2021 Mar; 268():113644. PubMed ID: 33264660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dauricine attenuates ovariectomized-induced bone loss and RANKL-induced osteoclastogenesis via inhibiting ROS-mediated NF-κB and NFATc1 activity.
    Lin X; Yuan G; Yang B; Xie C; Zhou Z; Liu Y; Liu Z; Wu Z; Akimoto Y; Li N; Xu R; Song F
    Phytomedicine; 2024 Jul; 129():155559. PubMed ID: 38579642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lactobacillus fermentation enhances the inhibitory effect of Hwangryun-haedok-tang in an ovariectomy-induced bone loss.
    Shim KS; Kim T; Ha H; Lee KJ; Cho CW; Kim HS; Seo DH; Ma JY
    BMC Complement Altern Med; 2013 May; 13():106. PubMed ID: 23680047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bu-Shen-Tong-Luo decoction prevents bone loss via inhibition of bone resorption and enhancement of angiogenesis in ovariectomy-induced osteoporosis of rats.
    Yuan H; Xiao L; Min W; Yuan W; Lu S; Huang G
    J Ethnopharmacol; 2018 Jun; 220():228-238. PubMed ID: 29317302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin Inhibits Osteoclastogenesis and Bone Loss in Ovariectomized Mice by Regulating PRMT1-Mediated Signaling.
    Choi JH; Jang AR; Park MJ; Kim DI; Park JH
    Endocrinology; 2021 Jun; 162(6):. PubMed ID: 33713122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.